DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Miao D, He B, Jiang Y. et al.
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.
J Clin Invest 2005;
115 (09) 2402-2411.
We do not assume any responsibility for the contents of the web pages of other providers.